Long-term cardiovascular complications in COVID-19 survivors according to disease severity
- PMID: 41162524
- PMCID: PMC12572387
- DOI: 10.1038/s41598-025-21711-1
Long-term cardiovascular complications in COVID-19 survivors according to disease severity
Abstract
Post-sepsis syndrome is a major concern affecting sepsis survivors. COVID-19 increases the risk of long-term complications, but existing data lack detail on patient-specific factors and long-term cardiovascular complications, namely major adverse cardiovascular events (MACE). Our objective was to analyze and compare the MACE occurrence, among COVID-19 survivors, according to the severity of infection. Adults aged ≥ 18 years infected during the first waves of COVID-19 pandemic hospitalized in Strasbourg University Hospital were included. Follow-up began immediately after COVID-19 diagnosis and continued for up to 12 months. Inverse probability of treatment weighting was used to balance baseline patient characteristics between the two groups (i.e. intensive care unit patients and medical ward patients). A total of 332 patients, i.e.132 in intensive care unit (ICU) and 200 in medical ward were included in the final analysis. The ICU population experienced a significantly higher risk of MACE during the first year (HR 16.2 [5.7-45.8] p < 0.001). Smoking status, history of peripheral arterial obstructive disease, and hospitalization in ICU remained independently associated with the occurrence of MACE in multivariable analysis. Severity of COVID-19 appears as an independent risk factor for MACE at one year among intensive care unit patients compared to those hospitalized in medical ward.
Keywords: COVID-19; Cardiovascular outcomes; MACE; Post-intensive care syndrome (PICS); SARS-CoV-2.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The local ethics committee of the University Hospital of Strasbourg approved the study (reference NCE-2020-51) and approval from the institutional review board for the research, the ethical principles stated by the Declaration of Helsinki, as well as all national legal and regulatory requirements. Consent for publication: All authors hereby consent to the publication. Competing interests: The authors declare no competing interests. Informed consent: has been obtained from all participants or their legal representatives.
Figures
References
-
- Gómez, G., Gómez-Mateu, M. & Dafni, U. Informed choice of composite end points in cardiovascular trials. Circ. Cardiovasc. Qual. Outcomes. 7 (1), 170–178 (2014). - PubMed
-
- Kosyakovsky, L. B. et al. Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis. Intensive Care Med. 47 (9), 931–942 (2021). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
